SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-002693
Filing Date
2023-03-02
Accepted
2023-03-02 16:31:21
Documents
101
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K icpt-20221231x10k.htm   iXBRL 10-K 3743878
2 EX-4.9 icpt-20221231xex4d9.htm EX-4.9 27673
3 EX-21.1 icpt-20221231xex21d1.htm EX-21.1 4484
4 EX-23.1 icpt-20221231xex23d1.htm EX-23.1 2684
5 EX-31.1 icpt-20221231xex31d1.htm EX-31.1 11830
6 EX-31.2 icpt-20221231xex31d2.htm EX-31.2 11718
7 EX-32 icpt-20221231xex32.htm EX-32 9738
8 GRAPHIC icpt-20221231x10k007.jpg GRAPHIC 46461
  Complete submission text file 0001558370-23-002693.txt   14862964

Data Files

Seq Description Document Type Size
9 EX-101.SCH icpt-20221231.xsd EX-101.SCH 79906
10 EX-101.CAL icpt-20221231_cal.xml EX-101.CAL 108683
11 EX-101.DEF icpt-20221231_def.xml EX-101.DEF 353916
12 EX-101.LAB icpt-20221231_lab.xml EX-101.LAB 729131
13 EX-101.PRE icpt-20221231_pre.xml EX-101.PRE 609688
95 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20221231x10k_htm.xml XML 3007479
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35668 | Film No.: 23699520
SIC: 2834 Pharmaceutical Preparations